摘要
背景:上皮间质转化(EMT)是肿瘤转移的主要决定因素,与TGF-β1密切相关。细胞内蛋白质,包括E.钙粘蛋白,N.钙粘蛋白和波形蛋白与EMT直接相关,影响细胞迁移和粘附;另一方面,非肌肉肌球蛋白(NM)在胞质分裂,迁移和粘附中具有核心作用。目的:通过调控非肌肉肌球蛋白II-A(NMII-A)及其与己糖胺生物合成途径(HBP)的相互作用,探讨EMT与转移与TGF-β1的关系。 方法:蛋白质表达的变化通过免疫印迹和免疫荧光染色进行评估,而通过qRT-PCR评估转录水平的变化。 EMT通过表型分析,伤口愈合,增殖和transwell迁移实验体外评估,而在BALB / c裸鼠体内研究肺原位和尾静脉转移模型。 结果:我们证明TGF-β1对JNK / P38 / PI3K的调节导致了NMII-A的下调,促进了EMT和肺癌的转移。 NMII-A的这种下调表达反过来上调核心2 N-乙酰葡糖胺基转移酶粘蛋白型(C2GnT-M)的表达,并进一步促进了N-乙酰葡糖胺转移酶(GnT)-V和-III的上调和下调;此外,NMII-A K.D细胞在体内显示出向脑部迁移3倍的倾向。 结论:本研究报道了NMII-A通过上调C2GnT-M,GnT-V和GnT-III的下调表达负调节EMT和转移的新途径。这些肺癌的发现可能还需要研究其他癌症类型。
关键词: NMII-A,EMT,C2GnT-M,GnT-III,GnT-V,GlcNAc,HBP,肺癌转移。
图形摘要
Current Cancer Drug Targets
Title:TGF-β1 Causes EMT by Regulating N-Acetyl Glucosaminyl Transferases via Downregulation of Non Muscle Myosin II-A through JNK/P38/PI3K Pathway in Lung Cancer
Volume: 18 Issue: 2
关键词: NMII-A,EMT,C2GnT-M,GnT-III,GnT-V,GlcNAc,HBP,肺癌转移。
摘要: Background: Epithelial to mesenchymal transition (EMT) is a major determinant of cancer metastasis and is closely linked with TGF-β1. Intracellular proteins, including E. Cadherin, N. Cadherin and Vimentin are directly related to EMT that affect cell migration and adhesion; on the other hand, non muscle myosin (NM) has a central role in cytokinesis, migration and adhesion.
Objective: We aimed to explore the association of EMT and metastasis with TGF-β1 through regulation of non-muscle myosin II-A (NMII-A) and its interaction with Hexosamine Biosynthesis Pathway (HBP).
Method: Protein expression changes were assessed by western blotting and immunofluorescent staining while transcription level changes were assessed by qRT-PCR. EMT was assessed by phenotypic analysis, wound healing, proliferation and transwell migration assay in vitro while in vivo studies were conducted in BALB/c nude mice for lung orthotopic and tail vein metastasis models.
Results: We demonstrated that regulation of JNK/ P38/PI3K by TGF-β1 led to down expression of NMII-A which promoted EMT and lung cancer metastasis. This down expression of NMII-A conversely upregulated the expression of Core 2 N-acetyl Glucosaminyl Transferase mucin type (C2GnT-M) and further facilitated up-regulation and down-regulation of N-acetylglucosaminyltransferase (GnT) -V and -III respectively; moreover, NMII-A K.D cells showed 3 times more tendency to migrate towards brain in vivo.
Conclusion: The study reports a novel pathway through which NMII-A negatively regulates EMT and metastasis via up regulation of C2GnT-M, GnT-V and down expression of GnT-III. These findings of lung cancer may further be required to study other cancer types.
Export Options
About this article
Cite this article as:
TGF-β1 Causes EMT by Regulating N-Acetyl Glucosaminyl Transferases via Downregulation of Non Muscle Myosin II-A through JNK/P38/PI3K Pathway in Lung Cancer, Current Cancer Drug Targets 2018; 18 (2) . https://dx.doi.org/10.2174/1568009617666170807120304
DOI https://dx.doi.org/10.2174/1568009617666170807120304 |
Print ISSN 1568-0096 |
Publisher Name Bentham Science Publisher |
Online ISSN 1873-5576 |
- Author Guidelines
- Graphical Abstracts
- Fabricating and Stating False Information
- Research Misconduct
- Post Publication Discussions and Corrections
- Publishing Ethics and Rectitude
- Increase Visibility of Your Article
- Archiving Policies
- Peer Review Workflow
- Order Your Article Before Print
- Promote Your Article
- Manuscript Transfer Facility
- Editorial Policies
- Allegations from Whistleblowers
Related Articles
-
Dendrimer-drug Conjugates in Drug Delivery and Targeting
Pharmaceutical Nanotechnology Anticancer Potential of Dietary Natural Products: A Comprehensive Review
Anti-Cancer Agents in Medicinal Chemistry Epigenetic Interventions Increase the Radiation Sensitivity of Cancer Cells
Current Pharmaceutical Design A Five-gene Signature for Predicting the Prognosis of Colorectal Cancer
Current Gene Therapy Interactions of Curcumin and Its Derivatives with Nucleic Acids and their Implications
Mini-Reviews in Medicinal Chemistry A Practical Approach to Diagnosis and Treatment of Symptomatic Thromboembolic Events in Children with Acute Lymphoblastic Leukemia: Recommendations of the “Coagulation Defects” AIEOP Working Group
Recent Patents on Cardiovascular Drug Discovery Induction of GST and Related Events by Dietary Phytochemicals: Sources, Chemistry, and Possible Contribution to Chemoprevention
Current Topics in Medicinal Chemistry Role of Resveratrol in Modulating microRNAs in Human Diseases: From Cancer to Inflammatory Disorder
Current Medicinal Chemistry Xanthones from Mangosteen Extracts as Natural Chemopreventive Agents: Potential Anticancer Drugs
Current Molecular Medicine The Role of Aryl Hydrocarbon Receptor-Regulated Cytochrome P450 Enzymes in Glioma
Current Pharmaceutical Design Star Graphs of Protein Sequences and Proteome Mass Spectra in Cancer Prediction
Current Proteomics The Development of Ataxia Telangiectasia Mutated Kinase Inhibitors
Mini-Reviews in Medicinal Chemistry Bioactive Albumin-Based Carriers for Tumour Chemotherapy
Current Cancer Drug Targets The Linkage Between Inflammation and Immune Tolerance: Interfering with Inflammation in Cancer
Current Cancer Drug Targets Drug-Membrane Interactions: Significance for Medicinal Chemistry
Current Medicinal Chemistry Smart Stimuli Sensitive Nanogels in Cancer Drug Delivery and Imaging: A Review
Current Pharmaceutical Design From Target Therapy to miRNA Therapeutics of Human Multiple Myeloma: Theoretical and Technological Issues in the Evolving Scenario
Current Drug Targets Targeting Aurora Kinases in Cancer Treatment
Current Drug Targets Molecular Targeted Therapies in the Management of Head and Neck Squamous Cell Carcinoma: Recent Developments and Perspectives
Anti-Cancer Agents in Medicinal Chemistry Furanodiene: A Novel, Potent, and Multitarget Cancer-fighting Terpenoid
Current Pharmaceutical Design